Sotevtamab, the novel dual-action antibody , is sparking considerable interest within the cancer community, particularly regarding the potential for treating hematologic malignancies . This therapy works by https://mayajqyv829075.blog5.net/93187016/sotevtamab-a-new-treatment-in-blood-malignancies